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ABSTRACT
Objective: To identify key stakeholder preferences and
priorities when considering a national healthcare-
associated infection (HAI) surveillance programme
through the use of a discrete choice experiment (DCE).
Setting: Australia does not have a national HAI
surveillance programme. An online web-based DCE was
developed and made available to participants in Australia.
Participants: A sample of 184 purposively selected
healthcare workers based on their senior leadership
role in infection prevention in Australia.
Primary and secondary outcomes: A DCE
requiring respondents to select 1 HAI surveillance
programme over another based on 5 different
characteristics (or attributes) in repeated hypothetical
scenarios. Data were analysed using a mixed logit
model to evaluate preferences and identify the relative
importance of each attribute.
Results: A total of 122 participants completed the
survey (response rate 66%) over a 5-week period.
Excluding 22 who mismatched a duplicate choice
scenario, analysis was conducted on 100 responses.
The key findings included: 72% of stakeholders
exhibited a preference for a surveillance programme
with continuous mandatory core components (mean
coefficient 0.640 (p<0.01)), 65% for a standard
surveillance protocol where patient-level data are
collected on infected and non-infected patients (mean
coefficient 0.641 (p<0.01)), and 92% for hospital-level
data that are publicly reported on a website and not
associated with financial penalties (mean coefficient
1.663 (p<0.01)).
Conclusions: The use of the DCE has provided a
unique insight to key stakeholder priorities when
considering a national HAI surveillance programme.
The application of a DCE offers a meaningful method
to explore and quantify preferences in this setting.
BACKGROUND
A healthcare-associated infection (HAI) is an
infection that occurs as a result of a
healthcare intervention.1 Common HAIs
include a bloodstream infection after the
insertion of an intravenous catheter, or a
wound infection following surgery.
Preventing HAIs requires a multimodal
approach.2 Although surveillance of HAIs is
acknowledged as crucial to HAI prevention,3
Australia is yet to develop a national HAI
programme, and existing State and Territory
programmes are known to have broad vari-
ation of practices and a lack of agreement in
identifying HAIs.4 5
There are many stakeholders in HAI sur-
veillance, these include clinicians, hospital
executives, governing and regulatory bodies,
funders and of course consumers. Ideally
data should be used by clinicians to drive
infection prevention efforts and reduce the
incidence of HAIs.6 Data have also been
used to measure hospital performance and,
despite a lack of evidence as a driver to
reduce infection, hospitals have been ﬁnan-
cially penalised based on these data.7 8 As
such, there are competing demands from a
surveillance programme.
A national HAI surveillance programme
designed to meet the needs of all stake-
holders may not be possible. This study
sought to employ discrete choice experiment
Strengths and limitations of this study
▪ This study is the first reported use of a discrete
choice experiment in the area of healthcare-asso-
ciated infection surveillance.
▪ The results offer a unique insight into the priorities
of stakeholders when considering healthcare-asso-
ciated infection surveillance programmes.
▪ Not all healthcare-associated infection surveil-
lance stakeholder groups participated.
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(DCE) methodology to identify the most important con-
siderations for those involved in HAI surveillance and to
assess the degree of convergence or otherwise in the
preferences of key stakeholder groups.
DCEs are a quantitative attribute-based survey method,
used to elicit preferences for healthcare products, inter-
ventions, services, policies or programmes.9–11 Typically,
DCEs offer participants a series of hypothetical choice
scenarios comprising two or more scenarios that vary
according to several key characteristics or attributes,
where the participants are required to indicate their pre-
ferred scenario.12 A form of stated preference, DCEs are
able to provide information on the relative importance
of the attributes presented in the hypothetical
scenarios.13
DCEs may be considered as more cognitively challen-
ging for participants than other ordinal approaches to
preference elicitation, for example, ranking and rating
methods.14 However, the main advantages of DCEs are
they present choices in a manner that is potentially
more relevant to the participants and they provide more
information as they generate quantitative data on the
strength of preferences and trade-offs, and the probabil-
ity of take up.9 13
Extensively used in health economics, DCEs have
recently been used to assist in developing priority setting
frameworks and clinical decision-making.10 In public
health settings, DCEs have been used for priority setting
frameworks where decision makers are required to
manage competing demands with limited resources.15–17
DCEs have also been used to predict uptake of new pol-
icies or programmes.18
The main objective of the study was to identify key
stakeholder preferences for a national surveillance pro-
gramme. This will provide crucial information on poten-
tial acceptance of a surveillance programme, and
provide insight into how stakeholders consider certain
elements of surveillance. These data will be vital for
informing the future design and implementation of a
national HAI surveillance programme in Australia.
METHODS
Identification of attributes and levels
There are several key stages in the development of a
DCE. The ﬁrst step in the construction of a DCE is the
identiﬁcation of attributes and levels of the intervention
being valued. The chosen attributes and their respective
levels are the key factors that will inﬂuence the choice of
one surveillance programme over another.14 Hence, it is
important that the chosen attributes and levels for the
DCE are realistic and salient to the participants within
the context in which the DCE is being applied.9 11 19
To identify the attributes and levels, we used two
methods commonly described in the literature.11 First, a
review of the literature was undertaken which identiﬁed
key articles describing health-related surveillance systems
and their attributes.20–22 Second, seven semistructured
interviews were conducted with experts in HAI surveil-
lance. Participants were purposively selected because of
their expertise in HAI surveillance and experience in
developing, implementing and maintaining large surveil-
lance programmes. Four interviews were with leaders
from four different international HAI surveillance pro-
grammes, two with leaders of different state surveillance
programmes in Australia and one interview with an
expert from a national body representing national sur-
veillance policy. Using attributes identiﬁed from the lit-
erature review, an interview guide was constructed for
the purpose of corroborating these attributes or identify-
ing new ones. Content analysis using interpretive
description was conducted on the transcripts of the
semistructured interviews to identify major themes,
which were then compared with the attributes identiﬁed
in the literature. Themes that did not align with those
from the literature were used to construct questions
about potential new attributes.
Initially 14 potential attributes were identiﬁed.
Following review, some of these attributes were collapsed
to form six major attributes. Through a series of discus-
sions between the researchers (PLR, LH, JR, GC) the
attributes were further reﬁned to ﬁve (ﬁgure 1). The
attributes deemed to be most important in the initial
design and implementation of a national HAI pro-
gramme were: (1) mandatory participation require-
ments, (2) the type of surveillance protocol, (3)
frequency of competency assessments of those collecting
data, (4) the overall accuracy of the data and, ﬁnally, (5)
how the data were to be reported.
The levels for each attribute were selected based on a
number of considerations. In accordance with best prac-
tice guidance for the design and conduct of DCEs in
healthcare, they needed to be plausible, actionable and
provide a range of options without being too extreme.23
The ﬁnal levels selected largely reﬂected a variety of
current practices from existing international and local,
state-based surveillance programmes. The ﬁnal attributes
and levels are described in more detail in box 1.
Experimental design
The ﬁve attributes and their corresponding levels resulted
in 216 proﬁles (=33×41×21), and a total of 23 220 possible
pair wise choice scenarios (=(216×215)/2). A D-efﬁcient
design (NGENE Manual 1.1.1 [computer program].
Choice Metrics, 2012)24 with no prior parameters informa-
tion (which minimise the Dz-error) was used to reduce the
number of choice scenarios into a more pragmatic
number of 24 choice scenarios for presentation using the
Ngene V.1.1.2 DCE design software (http://www.
choice-metrics.com). Ngene was also employed to divide
the resulting DCE design into two blocks, each containing
12 pair wise choice scenarios to reduce the size of the
questionnaire presented to participants. In each block,
one choice scenario was duplicated to form a test of
internal consistency. This resulted in a total of 13 choice
scenarios in each block.
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The survey
The survey was constructed using an online survey tool
(Key Survey [computer program]. MA: Braintree, 2015).
Prior to answering the choice questions, participants
were required to respond to ﬁve Likert scale attitudinal
questions regarding HAI surveillance. This was followed
by a detailed description of each of the attributes and
levels (box 1). A sample choice scenario was then
presented.
A hypothetical scenario was presented which informed
the participants a mandatory national HAI surveillance
programme was to be implemented, and assuming their
existing level of resourcing, they were requested to indi-
cate which of the two surveillance programmes pre-
sented they would consider most beneﬁcial to their
existing infection prevention programme (table 1).
Each choice scenario consisted of the same ﬁve
attributes but with differing levels. Participants were then
Figure 1 Development of attributes for the discrete choice experiment. (a) Resources required to undertake surveillance.
(b) Cost effectiveness of the healthcare-associated infection (HAI) surveillance programme. (c) Simplicity of the surveillance
programme, for example, amount of data required, ease of access to data. (d) Efficiency of surveillance processes (commonly
related to resources and simplicity). (e) Comparisons of HAI data with other like facilities or a benchmark. (f ) Flexibility of the
programme. For example, is it able to be tailored to meet individual needs, does it require all infections or is it targeted? (g)
Mandatory components required for participation. (h) Data quality such as completeness and sense, and related to validity,
accuracy and skill of data collectors. (i) Validity of the data, related to quality, accuracy and skill of data collectors. ( j) Training
and skill of those involved in collecting, analysing and reporting data. Is there a formal training programme, are skills assessed?
(k) Automation of surveillance, for example, electronic data systems, automated surveillance programmes. (l) Consistency of
surveillance, for example, consistent methods applied, definitions, analysis, risk adjustment. Related to training and skill of those
involved in surveillance. (m) Accuracy, sensitivity and specificity of the surveillance programme identified through formal studies.
(n) Public reporting, performance measures and financial penalties associated with HAI data. This relates to how data are used.
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randomised into one of two choice blocks. For each
choice question, participants were forced to choose one
or the other; there was no opt out option available. To
assist the participants understanding, a full deﬁnition of
each attribute and level was made visible using a hover
tool.
The ﬁnal section of the survey comprised ﬁve demo-
graphic questions regarding age, occupation, years of
experience in infection prevention, size of the hospital
they worked in (if applicable), State or Territory of
employment, and an open general comments question.
The survey was piloted by eight infection prevention
experts. Pilot participants indicated they found the DCE
easy to understand and complete. All eight correctly
matched the duplicate questions.
DCE participants
In total, 184 participants were purposively invited to
undertake the DCE over a 5-week period during June
and July 2015. These participants were selected because
they met at least one of the following criteria, they were:
▸ Coordinators of infection prevention programmes of
a network of acute care hospitals or at a single site
with >100 beds (there were 147 of these hospitals
identiﬁed in Australia25);
▸ Infectious diseases physicians or microbiologists
attached to infection prevention programmes at large
acute care hospitals;
▸ Senior health department employees or advisors
whose role inﬂuences national/state/territory infec-
tion prevention policy;
▸ Key stakeholders on national representative commit-
tees involved in national HAI surveillance initiatives;
▸ Considered by the research team (PLR and LH) to
be opinion leaders in infection prevention in
Australia.
Potential participants identiﬁed included 146 attached
to acute care hospitals, and another 38 non-hospital-
based stakeholders. Potential participants received a per-
sonalised email inviting them to undertake the survey.
Data analysis
The DCE data were analysed using a random utility
model,26 which could be speciﬁed empirically as:
Uitj ¼ x0itjbi þ 1itj
where Uitj is the utility individual i derives from choosing
alternative j in choice scenario t, xitj is a vector of
explanatory variables (ie, observed attributes), βi is a
vector of coefﬁcients reﬂecting the desirability of the
attributes, and εitj is a random error. Conditional on βi,
Box 1 Final attributes and levels for the discrete choice
experiment
Participation requirements (mandatory)
▸ Targeted 12 months/other 3 months—continuous 12 months
targeted surveillance on specified healthcare-associated infec-
tions (HAIs) with choice of others for minimum 3 months/
year.
▸ Targeted 3 months/other 3 months—minimum 3 months tar-
geted surveillance on specified HAIs with choice of others for
minimum 3 months/year.
▸ Complete choice 3 months—minimum 3 months surveillance
on your own choice of HAIs.
Surveillance protocol
▸ Light protocol—patient-level data on infected patients only,
and aggregated numbers of denominator is collected. Fewer
resources required. Does not allow for risk adjustment of HAI
rates. Limited ability to compare data externally.
▸ Standard protocol—patient-level data are collected on infected
and non-infected patients. More resources required. Allows for
risk adjustment of HAI rates. Good ability to compare data
externally.
Competency
After the initial surveillance training, surveillance staff are required
to undergo regular assessment to ensure skills are maintained.
▸ Every data submission period (eg, quarterly)—supports high
consistency of surveillance processes.
▸ Annually—supports reasonable consistency of surveillance
processes.
▸ Every 2 years—does not support high consistency of surveil-
lance processes.
Accuracy
It is unlikely that all data will be completely accurate all the time.
In general terms there will be an error margin with the HAI rates.
▸ Very accurate—approximately 1–5% error range
▸ Reasonably accurate—approximately 6–10% error range
▸ Less accurate—approximately 11–15% error range
Reporting
The reporting of HAI rates and their use as a performance
measure associated with financial penalties for the hospital within
a national surveillance programme.
▸ Public with no penalty—data publicly reported on website and
not associated with financial penalties.
▸ Public and with penalty—data publicly reported on website
and associated with financial penalties
▸ Not public but with penalty—data not publicly reported but
are associated with financial penalties.
▸ Not public and with no penalty—data not publicly reported
and not associated with financial penalties.
Table 1 Example of a choice scenario
Attributes
Surveillance
programme A
Surveillance
programme B
Participation
requirements
(mandatory)
Targeted
12 months/other
3 months
Complete choice
3 months
Surveillance
protocol
Light protocol Standard protocol
Competency Annually Every 2 years
Accuracy Very accurate Less accurate
Reporting Not public but
with penalty
Public and with
penalty
Which would you
prefer? (tick)
Surveillance
programme A
Surveillance
programme B
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it is assumed that εitj is independent and identically dis-
tributed extreme value type 1.
The conditional logit model is a classical method to
estimate the utility function.14 However, it assumes that
all respondents have the homogeneous preference for
the attributes (ie, βi=β). Allowing for the potential pref-
erence heterogeneity among respondents, the mixed
logit (MIXL) model has gained popularity recently.27–29
The MIXL model estimates both the mean and distribu-
tion for each attribute level (ie, βi=β+ηi, ηi is a vector of
individual-speciﬁc deviations from the mean). In this
study, it was assumed that all coefﬁcients of attribute
levels are random with normal distribution. The Akaike
information criterion was used to compare the overall ﬁt
of DCE models. Data were analysed using Stata, V.13
(Stata Corp, College Station, Texas, USA).
RESULTS
A total of 122 completed responses were received over a
5-week period (response rate 66%). Of the 122 respon-
dents, 98 (79%) were clinicians (infection prevention
nurses, infectious diseases physician and microbiologists),
and others were health department representatives or had
acted in a health department advisory role. There was pro-
portionate representation from all State and Territories,
76% had >10 years experience in infection prevention and
66% were aged over 50 years. Of the 93 respondents
whose primary employment was in a hospital, 43 (46%)
worked in a hospital with >400 beds. Further details of
respondent characteristics are listed in table 2.
A total of 22 (18%) respondents mismatched the
duplicate choice scenario. Analysis of the DCE output
was undertaken on the full data set (with mismatches)
and the data set with the mismatches excluded. The
results of both data sets were very similar; however, it was
decided to present results excluding the mismatched
respondents on the basis that it could not be assumed
that these respondents fully understood the DCE, pro-
viding a useable response rate of n=100 for data analysis
(see online supplementary table S1 for results on full
data set).
Results of the MIXL estimates are presented in
table 3. It can be seen that all attributes were found to
have a statistically signiﬁcant inﬂuence on the prefer-
ences for a HAI surveillance programme.
The results identify key stakeholders strongest prefer-
ences were for a surveillance programme that has:
▸ A mandated continuous targeted surveillance on spe-
ciﬁed HAIs with choice of others for a minimum
3 months/year (followed by minimum 3 months tar-
geted surveillance on speciﬁed HAIs with choice of
others for minimum 3 months/year);
▸ The standard surveillance protocol where patient-
level data are collected on infected and non-infected
patients;
▸ Annual competency assessments of data collectors
(followed by competency assessments every data sub-
mission period);
▸ Very accurate data (followed closely by reasonably
accurate data); and
▸ Hospital-level data publicly reported on a website and
not associated with ﬁnancial penalties (followed by
hospital-level data not publicly reported and not asso-
ciated with ﬁnancial penalties).
The statistical signiﬁcance of the SD coefﬁcients for all
but one of the attribute levels (annual competency) con-
ﬁrms the existence of preference heterogeneity for the
majority of the attributes. As all coefﬁcients for attribute
levels are assumed to be normally distributed, the MIXL
estimates relating to the mean coefﬁcient and SD for
each attribute level were used to calculate the distribu-
tion of preference heterogeneity.30 For example, the
coefﬁcient (SD) for the level of targeted 12-month with
choice of 3-month surveillance is 0.640 (1.083) indicates
72% of the respondents exhibited a preference for tar-
geted 12 months with choice of 3-month surveillance
over a complete choice of surveillance for 3 months.
Similarly 65% of respondents had a preference for
standard protocol over light, and 86% preferring very
Table 2 Respondent characteristics
Characteristic
Percent
(n=122)
Age bracket
<30 0.8
30–39 9.0
40–49 24.6
50–59 46.7
>59 18.9
Occupation
Health department representative 10.7
Infection prevention nurse 65.6
Infectious diseases physician 13.1
Other 10.7
Years experience in infection prevention
<5 4.9
5–10 17.2
11–15 27.9
16–20 19.7
>20 27.9
NA 2.5
Number of acute beds
<100 2.5
100–199 13.1
200–400 25.4
>400 35.3
NA 23.8
State or Territory
Australian Capital or Northern
Territory
4.9
New South Wales 27.1
Queensland 17.2
South Australia 7.4
Tasmania 5.7
Victoria 27.9
Western Australia 9.8
NA, not applicable.
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accurate data over less accurate and 92% demonstrated
a preference for data to be reported public with no
penalty over publicly reported with penalty.
Subgroup analyses were conducted using conditional
logit model and reported in online supplementary
tables S2a and S2b. However, owing to the small sample
size in the subgroups, the results should be interpreted
with caution. One interesting ﬁnding worth highlighting
here is that when occupation was divided into clinician
and non-clinician, it was found that clinicians preferred
very accurate data (p<0.01), non-clinicians preferred
mostly accurate data (p<0.05; full results included in
online supplementary tables S2a and S2b).
DISCUSSION
This novel application of a DCE has identiﬁed the pre-
ferences of key stakeholders for a national HAI surveil-
lance programme.
This study indicates key stakeholder preference for a
national HAI surveillance programme that has manda-
tory continuous surveillance on targeted infections with
an option to choose surveillance in other areas, a proto-
col that facilitates risk adjustment for meaningful com-
parisons, and annual competency assessments of those
who undertake the surveillance. The preference is for
HAI data to be highly accurate and publicly reported,
but not to be associated with any ﬁnancial penalties.
A surprising result was the preference for annual com-
petency assessments over the more frequent every data
submission (quarterly). One explanation may be that
competency assessments every data submission may have
been considered too resource intensive when compared
against an annual assessment.
There are several important points in this study. First,
the DCE was constructed based on the ﬁndings from a
literature review and a series of semistructured interviews
with experts in HAI surveillance. This means that the
attributes and levels were relevant and meaningful to
participants. Second, an attractive feature of a DCE is its
ability to provide information about the acceptability (or
otherwise) of different characteristics of programmes
not yet available in practice.31 This is a crucial point, par-
ticularly when considering issues around implementa-
tion. Third, the results provide a unique insight into
HAI surveillance issues not previously demonstrated in
Australia. This study provides evidence identifying the
speciﬁc characteristics of a HAI surveillance programme
that are acceptable to key stakeholders, which, if they
are included in a national programme, will increase the
likelihood of successful implementation. And ﬁnally,
given the multimodal approach to infection prevention,
and the competing interests of multiple stakeholders, we
suggest that DCEs have the potential to clearly identify
priority frameworks in this setting given competing
demands and limited resources.
A potential limitation of DCEs is that there is some evi-
dence to indicate that respondents tend to make their
choices on the basis of familiarity, that is, they tend to
express a preference for the status quo,32 and this may
explain some of the preference choices observed in this
study. Twenty-two respondents mismatched the duplicate
choice scenario. This could mean that some found the
DCE challenging; alternatively, it may be that some
respondents changed their preferences as they worked
through the DCE. Nevertheless, analyses of data both
with and without these mismatches indicated very
similar results and did not alter the main ﬁndings.
Table 3 Mixed logit estimates for sample excluding participants who mismatched duplicate question
Mean coefficient SD
Attribute Level Coefficient SE Coefficient SE
Participation requirements (mandatory) Targeted 12 months/other 3 months 0.640** 0.198 1.083** 0.268
Targeted 3 months/other 3 months 0.331* 0.158 0.619* 0.281
Complete choice 3 months Reference
Surveillance protocol Standard protocol 0.641** 0.204 1.698** 0.240
Light protocol Reference
Competency Every data submission period 0.546** 0.202 1.325** 0.243
Annually 0.778** 0.170 0.044 0.367
Every 2 years Reference
Accuracy Very accurate 1.132** 0.204 1.031** 0.229
Reasonably accurate 0.977** 0.201 0.754** 0.260
Less accurate Reference
Reporting Public with no penalty 1.663** 0.277 1.163** 0.274
Not public but with penalty 0.467* 0.194 0.971** 0.337
Not public and with no penalty 0.725** 0.232 1.453** 0.258
Public and with penalty Reference
N 100
Observations 2400
**p<0.01, *p<0.05.
Log likelihood −674.968.
All attributes were dummy coded.
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Another potential limitation is that the not all key stake-
holder groups were able to be included in this study for
practicality reasons, in particular hospital executive and
quality and safety staff. However, major strengths of this
study are the inclusion of attributes identiﬁed through
qualitative research methods that are relevant and mean-
ingful, its speciﬁc targeting of leaders in infection pre-
vention programmes, the national sample frame, and a
high response rate.
Our study is the ﬁrst application of a discrete choice
analysis to identify key stakeholder preferences and pri-
orities for HAI surveillance. Given the multimodal
approach to infection prevention, and the competing
interests of multiple stakeholders, DCEs have the poten-
tial to clearly identify priority frameworks in this setting,
where competing demands and limited resources have
been clearly demonstrated.33 34
CONCLUSIONS
This paper describes the novel application of a DCE to
identify stakeholder preferences for a national HAI sur-
veillance programme that can be used to inform
evidence-based recommendations.
In HAI prevention where there are many key stake-
holders from a variety of settings with differing and com-
peting priorities, the application of a DCE has the potential
to explore and quantify preferences in this setting.
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